MCL1 and cancer: It is plausible to speculate that many of the malignancies with elevated expression of Mcl-1 will benefit from treatment with Mcl-1 specific inhibitors either alone or in combination with other anti-cancer agents (Merino et al., 2018; Xiang et al., 2018; Kelly and Strasser, 2020).